# QUE-259 per-region diagnostic: OCR determination + Camelot+LLM comparability

doc          pg ocr_ran  frac  conf    dRxC dCells cam_acc  cam?  verdict
101230425     3    True   1.0  0.98    40x6    191     0.0 False  OCR-only (docling recovered, Camelot empty)
101230425     4    True   1.0  0.98    41x8    300     0.0 False  OCR-only (docling recovered, Camelot empty)
101230425     5    True   1.0  0.97    52x4    184     0.0 False  OCR-only (docling recovered, Camelot empty)
101230425     6    True   1.0  0.98    50x6    270     0.0 False  OCR-only (docling recovered, Camelot empty)
101230425     7    True   1.0  0.99    44x6    223     0.0 False  OCR-only (docling recovered, Camelot empty)
101230425     8    True   1.0  0.97    46x8    246     0.0 False  OCR-only (docling recovered, Camelot empty)
102174103    11   False   0.0   0.0    33x3     84   97.72  True  text-layer (both can read)
102174103    12   False   0.0   0.0    15x5     67   96.43  True  text-layer (both can read)

## Example -- OCR-only (docling recovered, Camelot empty)  (101230425 p3)
OCR ran: True (frac=1.0, conf=0.98, 200 cells)
docling reconstruction: 40x6, 191 non-empty cells
```
|                                                     |              |              |              | FortheThreeMonthsEnded FortheSixMonthsEnded   | FortheThreeMonthsEnded FortheSixMonthsEnded   |
|-----------------------------------------------------|--------------|--------------|--------------|-----------------------------------------------|-----------------------------------------------|
| (Unaudited) (Dollarsinthousands,exceptpersharedata) | Jun.30, 2024 | Mar.31, 2024 | Jun.30, 2023 | Jun.30, 2024                                  | Jun.30. 2023                                  |
| FINANCI
```
Camelot+LLM: accuracy=0.0 nonempty=False (match cov=1.0)
```
(empty)
```

## Example -- text-layer (both can read)  (102174103 p11)
OCR ran: False (frac=0.0, conf=0.0, 94 cells)
docling reconstruction: 33x3, 84 non-empty cells
```
|                                                                                                                            | December 31,   | December 31,   |
|----------------------------------------------------------------------------------------------------------------------------|----------------|----------------|
| (dollars and shares in millions, except per share amounts)                                                                 | 2023           | 2022           |
| Assets                                                                                                             
```
Camelot+LLM: accuracy=97.72 nonempty=True (match cov=1.0)
```
| | December 31, 2023 | December 31, 2022 |
| --- | --- | --- |
| **Assets** | | |
| **Current assets:** | | |
| Cash and cash equivalents | $ 311.7 | $ 81.3 |
| Restricted cash | 5.5 | 5.5 |
| Marketable securities | 949.3 | 1,124.0 |
| Accounts receivable | — | 1.0 |
| Other receivables | 7.2 | 7.0 |
| Prepaid expenses and other current assets | 6.5 | 21.4 |
| Total current assets | 1,280.2 | 1,240.2 |
| Property, equipment and leasehold improvements, net | 11.5 | 13.4 |
| Operating lease right of use assets | 2.5 | 4.4 |
| Collaboration contract asset and other assets | 10.4 | 10.8 |
| **To
```